Thyroid hormones explained

File:Thyroid_system.svg|thumb|upright=1.5|The thyroid system of the thyroid hormones T3 and T4[1]

rect 376 268 820 433 Thyroid-stimulating hormonerect 411 200 849 266 Thyrotropin-releasing hormonerect 297 168 502 200 Hypothalamusrect 66 216 386 256 Anterior pituitary glandrect 66 332 342 374 Negative feedbackrect 308 436 510 475 Thyroid glandrect 256 539 563 635 Thyroid hormonesrect 357 827 569 856 Catecholaminerect 399 716 591 750 Metabolism

desc bottom-leftThyroid hormones are any hormones produced and released by the thyroid gland, namely triiodothyronine (T3) and thyroxine (T4). They are tyrosine-based hormones that are primarily responsible for regulation of metabolism. T3 and T4 are partially composed of iodine, derived from food.[2] A deficiency of iodine leads to decreased production of T3 and T4, enlarges the thyroid tissue and will cause the disease known as simple goitre.[3]

The major form of thyroid hormone in the blood is thyroxine (T4), whose half-life of around one week[4] is longer than that of T3.[5] In humans, the ratio of T4 to T3 released into the blood is approximately 14:1.[6] T4 is converted to the active T3 (three to four times more potent than T4) within cells by deiodinases (5′-deiodinase). These are further processed by decarboxylation and deiodination to produce iodothyronamine (T1a) and thyronamine (T0a). All three isoforms of the deiodinases are selenium-containing enzymes, thus dietary selenium is essential for T3 production.

The thyroid hormone is one of the factors responsible for the modulation of energy expenditure. This is achieved through several mechanisms, such as mitochondrial biogenesis, adaptive thermogenesis, etc.[7]

American chemist Edward Calvin Kendall was responsible for the isolation of thyroxine in 1915.[8] In 2020, levothyroxine, a manufactured form of thyroxine, was the second most commonly prescribed medication in the United States, with more than 98million prescriptions.[9] [10] Levothyroxine is on the World Health Organization's List of Essential Medicines.[11]

Function

The thyroid hormones act on nearly every cell in the body. It acts to increase the basal metabolic rate, affect protein synthesis, help regulate long bone growth (synergy with growth hormone) and neural maturation, and increase the body's sensitivity to catecholamines (such as adrenaline) by permissiveness. The thyroid hormones are essential to proper development and differentiation of all cells of the human body. These hormones also regulate protein, fat, and carbohydrate metabolism, affecting how human cells use energetic compounds. They also stimulate vitamin metabolism. Numerous physiological and pathological stimuli influence thyroid hormone synthesis.

Thyroid hormone leads to heat generation in humans. However, the thyronamines function via some unknown mechanism to inhibit neuronal activity; this plays an important role in the hibernation cycles of mammals and the moulting behaviour of birds. One effect of administering the thyronamines is a severe drop in body temperature.

Medical use

Both T3 and T4 are used to treat thyroid hormone deficiency (hypothyroidism). They are both absorbed well by the stomach, so can be given orally. Levothyroxine is the chemical name of the manufactured version of T4, which is metabolised more slowly than T3 and hence usually only needs once-daily administration. Natural desiccated thyroid hormones are derived from pig thyroid glands, and are a "natural" hypothyroid treatment containing 20% T3 and traces of T2, T1 and calcitonin.Also available are synthetic combinations of T3/T4 in different ratios (such as liotrix) and pure-T3 medications (INN: liothyronine).Levothyroxine Sodium is usually the first course of treatment tried. Some patients feel they do better on desiccated thyroid hormones; however, this is based on anecdotal evidence and clinical trials have not shown any benefit over the biosynthetic forms.[12] Thyroid tablets are reported to have different effects, which can be attributed to the difference in torsional angles surrounding the reactive site of the molecule.[13]

Thyronamines have no medical usages yet, though their use has been proposed for controlled induction of hypothermia, which causes the brain to enter a protective cycle, useful in preventing damage during ischemic shock.

Synthetic thyroxine was first successfully produced by Charles Robert Harington and George Barger in 1926.

Formulations

thumb|right|Structure of (S)-thyroxine (T4)thumb|right|(S)-triiodothyronine (T3, also called liothyronine)

Most people are treated with levothyroxine, or a similar synthetic thyroid hormone.[14] [15] [16] Different polymorphs of the compound have different solubilities and potencies.[17] Additionally, natural thyroid hormone supplements from the dried thyroids of animals are still available.[18] [19] Levothyroxine contains T4 only and is therefore largely ineffective for patients unable to convert T4 to T3.[20] These patients may choose to take natural thyroid hormone, as it contains a mixture of T4 and T3,[21] [22] [23] [24] or alternatively supplement with a synthetic T3 treatment.[25] In these cases, synthetic liothyronine is preferred due to the potential differences between the natural thyroid products. Some studies show that the mixed therapy is beneficial to all patients, but the addition of lyothyronine contains additional side effects and the medication should be evaluated on an individual basis.[26] Some natural thyroid hormone brands are FDA approved, but some are not.[27] [28] [29] Thyroid hormones are generally well tolerated. Thyroid hormones are usually not dangerous for pregnant women or nursing mothers, but should be given under a doctor's supervision. In fact, if a woman who is hypothyroid is left untreated, her baby is at a higher risk for birth defects. When pregnant, a woman with a low-functioning thyroid will also need to increase her dosage of thyroid hormone. One exception is that thyroid hormones may aggravate heart conditions, especially in older patients; therefore, doctors may start these patients on a lower dose and work up to a larger one to avoid risk of heart attack.

Thyroid metabolism

Central

Thyroid hormones (T4 and T3) are produced by the follicular cells of the thyroid gland and are regulated by TSH made by the thyrotropes of the anterior pituitary gland. The effects of T4 in vivo are mediated via T3 (T4 is converted to T3 in target tissues). T3 is three to five times more active than T4.

T4, Thyroxine (3,5,3′,5′-tetraiodothyronine), is produced by follicular cells of the thyroid gland. It is produced from the precursor thyroglobulin (this is not the same as thyroxine-binding globulin (TBG)), which is cleaved by enzymes to produce active T4.[30]

The steps in this process are as follows:

  1. The Na+/I− symporter transports two sodium ions across the basement membrane of the follicular cells along with an iodide ion. This is a secondary active transporter that utilises the concentration gradient of Na+ to move I− against its concentration gradient.
  2. I− is moved across the apical membrane into the colloid of the follicle by pendrin.
  3. Thyroperoxidase oxidizes two I− to form I2. Iodide is non-reactive, and only the more reactive iodine is required for the next step.
  4. The thyroperoxidase iodinates the tyrosyl residues of the thyroglobulin within the colloid. The thyroglobulin was synthesised in the ER of the follicular cell and secreted into the colloid.
  5. Iodinated Thyroglobulin binds megalin for endocytosis back into cell.
  6. Thyroid-stimulating hormone (TSH) released from the anterior pituitary (also known as the adenohypophysis) binds the TSH receptor (a Gs protein-coupled receptor) on the basolateral membrane of the cell and stimulates the endocytosis of the colloid.
  7. The endocytosed vesicles fuse with the lysosomes of the follicular cell. The lysosomal enzymes cleave the T4 from the iodinated thyroglobulin.
  8. The thyroid hormones cross the follicular cell membrane towards the blood vessels by an unknown mechanism. Text books have stated that diffusion is the main means of transport,[31] but recent studies indicate that monocarboxylate transporter (MCT) 8 and 10 play major roles in the efflux of the thyroid hormones from the thyroid cells.[32] [33]

Thyroglobulin (Tg) is a 660 kDa, dimeric protein produced by the follicular cells of the thyroid and used entirely within the thyroid gland.[34] Thyroxine is produced by attaching iodine atoms to the ring structures of this protein's tyrosine residues; thyroxine (T4) contains four iodine atoms, while triiodothyronine (T3), otherwise identical to T4, has one less iodine atom per molecule.[35] The thyroglobulin protein accounts for approximately half of the protein content of the thyroid gland.[36] Each thyroglobulin molecule contains approximately 100 - 120 tyrosine residues, a small number of which (<20) are subject to iodination catalysed by thyroperoxidase.[37] The same enzyme then catalyses "coupling" of one modified tyrosine with another, via a free-radical-mediated reaction, and when these iodinated bicyclic molecules are released by hydrolysis of the protein, T3 and T4 are the result.[38] Therefore, each thyroglobulin protein molecule ultimately yields very small amounts of thyroid hormone (experimentally observed to be on the order of 5 - 6 molecules of either T4 or T3 per original molecule of thyroglobulin).[37]

More specifically, the monatomic anionic form of iodine, iodide (I—), is actively absorbed from the bloodstream by a process called iodide trapping.[39] In this process, sodium is cotransported with iodide from the basolateral side of the membrane into the cell, and then concentrated in the thyroid follicles to about thirty times its concentration in the blood.[40] [41] Then, in the first reaction catalysed by the enzyme thyroperoxidase, tyrosine residues in the protein thyroglobulin are iodinated on their phenol rings, at one or both of the positions ortho to the phenolic hydroxyl group, yielding monoiodotyrosine (MIT) and diiodotyrosine (DIT), respectively. This introduces 1 - 2 atoms of the element iodine, covalently bound, per tyrosine residue.[42] The further coupling together of two fully iodinated tyrosine residues, also catalysed by thyroperoxidase, yields the peptidic (still peptide-bound) precursor of thyroxine, and coupling one molecule of MIT and one molecule of DIT yields the comparable precursor of triiodothyronine:[43]

(Coupling of DIT to MIT in the opposite order yields a substance, r-T3, which is biologically inactive.[44]) Hydrolysis (cleavage to individual amino acids) of the modified protein by proteases then liberates T3 and T4, as well as the non-coupled tyrosine derivatives MIT and DIT.[45] [46] The hormones T4 and T3 are the biologically active agents central to metabolic regulation.[47]

Peripheral

Thyroxine is believed to be a prohormone and a reservoir for the most active and main thyroid hormone T3.[48] T4 is converted as required in the tissues by iodothyronine deiodinase.[49] Deficiency of deiodinase can mimic hypothyroidism due to iodine deficiency.[50] T3 is more active than T4,[51] though it is present in less quantity than T4.

Initiation of production in fetuses

Thyrotropin-releasing hormone (TRH) is released from hypothalamus by 6 – 8 weeks, and thyroid-stimulating hormone (TSH) secretion from fetal pituitary is evident by 12 weeks of gestation, and fetal production of thyroxine (T4) reaches a clinically significant level at 18–20 weeks.[52] Fetal triiodothyronine (T3) remains low (less than 15 ng/dL) until 30 weeks of gestation, and increases to 50 ng/dL at term.[52] Fetal self-sufficiency of thyroid hormones protects the fetus against e.g. brain development abnormalities caused by maternal hypothyroidism.[53]

Iodine deficiency

If there is a deficiency of dietary iodine, the thyroid will not be able to make thyroid hormones.[54] The lack of thyroid hormones will lead to decreased negative feedback on the pituitary, leading to increased production of thyroid-stimulating hormone, which causes the thyroid to enlarge (the resulting medical condition is called endemic colloid goitre; see goitre).[55] This has the effect of increasing the thyroid's ability to trap more iodide, compensating for the iodine deficiency and allowing it to produce adequate amounts of thyroid hormone.[56]

Circulation and transport

Plasma transport

Most of the thyroid hormone circulating in the blood is bound to transport proteins, and only a very small fraction is unbound and biologically active. Therefore, measuring concentrations of free thyroid hormones is important for diagnosis, while measuring total levels can be misleading.

Thyroid hormone in the blood is usually distributed as follows:

Type Percent - bound to thyroxine-binding globulin (TBG)70% - bound to transthyretin or "thyroxine-binding prealbumin" (TTR or TBPA) 10–15% - 15–20% - unbound T4 (fT4) 0.03% - unbound T3 (fT3) 0.3%

Despite being lipophilic, T3 and T4 cross the cell membrane via carrier-mediated transport, which is ATP-dependent.[57]

T1a and T0a are positively charged and do not cross the membrane; they are believed to function via the trace amine-associated receptor (TAR1, TA1), a G-protein-coupled receptor located in the cytoplasm.

Another critical diagnostic tool is measurement of the amount of thyroid-stimulating hormone (TSH) that is present.

Membrane transport

Contrary to common belief, thyroid hormones cannot traverse cell membranes in a passive manner like other lipophilic substances. The iodine in o-position makes the phenolic OH-group more acidic, resulting in a negative charge at physiological pH. However, at least 10 different active, energy-dependent and genetically regulated iodothyronine transporters have been identified in humans. They guarantee that intracellular levels of thyroid hormones are higher than in blood plasma or interstitial fluids.[58]

Intracellular transport

Little is known about intracellular kinetics of thyroid hormones. However, recently it could be demonstrated that the crystallin CRYM binds 3,5,3′-triiodothyronine in vivo.[59]

Mechanism of action

See main article: Thyroid hormone receptor.

The thyroid hormones function via a well-studied set of nuclear receptors, termed the thyroid hormone receptors. These receptors, together with corepressor molecules, bind DNA regions called thyroid hormone response elements (TREs) near genes. This receptor-corepressor-DNA complex can block gene transcription. Triiodothyronine (T3), which is the active form of thyroxine (T4), goes on to bind to receptors. The deiodinase catalyzed reaction removes an iodine atom from the 5′ position of the outer aromatic ring of thyroxine's (T4) structure.[60] When triiodothyronine (T3) binds a receptor, it induces a conformational change in the receptor, displacing the corepressor from the complex. This leads to recruitment of coactivator proteins and RNA polymerase, activating transcription of the gene.[61] Although this general functional model has considerable experimental support, there remain many open questions.[62]

More recently genetic evidence has been obtained for a second mechanism of thyroid hormone action involving one of the same nuclear receptors, TRβ, acting rapidly in the cytoplasm through the PI3K.[63] [64] This mechanism is conserved in all mammals but not fish or amphibians, and regulates brain development and adult metabolism. The mechanism itself parallels the actions of the nuclear receptor in the nucleus: in the absence of hormone, TRβ binds to PI3K and inhibits its activity, but when hormone binds the complex dissociates, PI3K activity increases, and the hormone bound receptor diffuses into the nucleus.

Thyroxine, iodine and apoptosis

Thyroxine and iodine stimulate the apoptosis of the cells of the larval gills, tail and fins in amphibian metamorphosis, and stimulate the evolution of their nervous system transforming the aquatic, vegetarian tadpole into the terrestrial, carnivorous frog. In fact, amphibian frog Xenopus laevis serves as an ideal model system for the study of the mechanisms of apoptosis.[65] [66] [67] [68]

Effects of triiodothyronine

Effects of triiodothyronine (T3) which is the metabolically active form:

Measurement

Further information: Thyroid function tests

Triiodothyronine (T3) and thyroxine (T4) can be measured as free T3 and free T4, which are indicators of their activities in the body.[70] They can also be measured as total T3 and total T4, which depend on the amount that is bound to thyroxine-binding globulin (TBG). A related parameter is the free thyroxine index, which is total T4 multiplied by thyroid hormone uptake, which, in turn, is a measure of the unbound TBG.[71] Additionally, thyroid disorders can be detected prenatally using advanced imaging techniques and testing fetal hormone levels.[72]

Related diseases

Both excess and deficiency of thyroxine can cause disorders.

Preterm births can suffer neurodevelopmental disorders due to lack of maternal thyroid hormones, at a time when their own thyroid is unable to meet their postnatal needs.[82] Also in normal pregnancies, adequate levels of maternal thyroid hormone are vital in order to ensure thyroid hormone availability for the foetus and its developing brain.[83] Congenital hypothyroidism occurs in every 1 in 1600–3400 newborns with most being born asymptomatic and developing related symptoms weeks after birth.[84]

Anti-thyroid drugs

Iodine uptake against a concentration gradient is mediated by a sodium–iodine symporter and is linked to a sodium-potassium ATPase. Perchlorate and thiocyanate are drugs that can compete with iodine at this point. Compounds such as goitrin, carbimazole, methimazole, propylthiouracil can reduce thyroid hormone production by interfering with iodine oxidation.[85]

Notes and References

  1. References used in image are found in image article in Commons:.
  2. Web site: How Your Thyroid Works . Sargis . Robert M. . endocrineweb.com . 21 October 2019 . 20 May 2023 .
  3. Book: Textbook of Surgery . 376 . Ijaz Ahsan . CRC Press . 1997. 9789057021398 .
  4. News: How long does thyroxine stay in your system? . Drugs.com . 6 August 2022.
  5. Web site: Thyroid Hormone Toxicity. Irizarry. Lisandro . vanc . Medscape. WedMD LLC. 23 April 2014. 2 May 2014.
  6. Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F, Bianchi R . Thyroidal and peripheral production of 3,5,3′-triiodothyronine in humans by multicompartmental analysis . The American Journal of Physiology . 258 . 4 Pt 1 . E715–E726 . April 1990 . 2333963 . 10.1152/ajpendo.1990.258.4.E715 .
  7. Tran . Le Trung . Park . Sohee . Kim . Seul Ki . Lee . Jin Sun . Kim . Ki Woo . Kwon . Obin . April 2022 . Hypothalamic control of energy expenditure and thermogenesis . Experimental & Molecular Medicine . en . 54 . 4 . 358–369 . 10.1038/s12276-022-00741-z . 2092-6413 . 9076616 . 35301430.
  8. Web site: 1926 Edward C Kendall. American Society for Biochemistry and Molecular Biology. 4 July 2011. 19 March 2012. https://web.archive.org/web/20120319051738/http://www.asbmb.org/uploadedfiles/aboutus/asbmb_history/past_presidents/1920s/1926Kendall.html. dead.
  9. Web site: The Top 300 of 2020 . ClinCalc . 7 October 2022.
  10. Web site: Levothyroxine - Drug Usage Statistics . ClinCalc . 7 October 2022.
  11. Book: ((World Health Organization)) . World Health Organization model list of essential medicines: 21st list 2019 . 2019 . 10665/325771 . World Health Organization . World Health Organization . Geneva . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO . free .
  12. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L . Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials . The Journal of Clinical Endocrinology and Metabolism . 91 . 7 . 2592–2599 . July 2006 . 16670166 . 10.1210/jc.2006-0448 . free .
  13. Schweizer U, Steegborn C . Thyroid hormones--From Crystal Packing to Activity to Reactivity . Angewandte Chemie . 54 . 44 . 12856–12858 . October 2015 . 26358899 . 10.1002/anie.201506919 .
  14. Robert Lloyd Segal, MD Endocrinologist
  15. Web site: preferred thyroid hormone --Levothyroxine Sodium (Synthroid, Levoxyl, Levothroid, Unithroid) . MedicineNet.com . 27 March 2009 .
  16. Web site: Hypothyroidism Causes, Symptoms, Diagnosis, Treatment Information Produced by Medical Doctors . MedicineNet.com . 27 March 2009 .
  17. Mondal S, Mugesh G . Structure Elucidation and Characterization of Different Thyroxine Polymorphs . Angewandte Chemie . 54 . 37 . 10833–10837 . September 2015 . 26213168 . 10.1002/anie.201505281 .
  18. Cooper DS . Thyroid hormone treatment: new insights into an old therapy . JAMA . 261 . 18 . 2694–2695 . May 1989 . 2709547 . 10.1001/jama.1989.03420180118042 .
  19. Clyde PW, Harari AE, Mohamed Shakir KM . Synthetic Thyroxine vs Desiccated Thyroid -Reply (citing Cooper, DS, above) . JAMA: The Journal of the American Medical Association . 2004 . 291 . 12 . 1445 . 10.1001/jama.291.12.1445-b .
  20. Wiersinga WM . Thyroid hormone replacement therapy . Hormone Research . 56 . Suppl 1 . 74–81 . 2001 . 11786691 . 10.1159/000048140 . 46756918 .
  21. http://thyroid.about.com/od/thyroiddrugstreatments/a/refusingmeds.htm "Consequences of Not Taking Thyroid Medications - Implications of Failing to Take Prescription Thyroid Drugs"
  22. http://www.armourthyroid.com/ "Armour Thyroid"
  23. http://www.nature-throid.com/ "Nature-Throid"
  24. http://thyroid.about.com/b/2008/09/10/armour-thyroid-shortages-worsening-what-can-thyroid-patients-do.htm "Armour Thyroid Shortages Worsening: What Can Thyroid Patients Do?"
  25. https://web.archive.org/web/20100628160635/http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0000685 Liothyronine
  26. Escobar-Morreale HF, Botella-Carretero JI, Morreale de Escobar G . Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine . Best Practice & Research. Clinical Endocrinology & Metabolism . 29 . 1 . 57–75 . January 2015 . 25617173 . 10.1016/j.beem.2014.10.004 . 10261/124621 . free .
  27. http://www.usdoctor.com/thyroid.htm "Thyroid Information"
  28. Eliason BC, Doenier JA, Nuhlicek DN . Desiccated thyroid in a nutritional supplement . The Journal of Family Practice . 38 . 3 . 287–288 . March 1994 . 8126411 .
  29. http://drugs.emedtv.com/nature-throid/nature-throid.html "Nature-Throid"
  30. Book: https://www.ncbi.nlm.nih.gov/books/NBK28/ . Endocrinology: An Integrated Approach . The thyroid gland . 28 March 2024 . BIOS Scientific Publishers .
  31. Book: Human Anatomy & Physiology, Sixth Edition. Benjamin Cummings. 2 May 2003. 978-0805354621. registration.
  32. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ . Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10 . Molecular Endocrinology . 22 . 6 . 1357–1369 . June 2008 . 18337592 . 5419535 . 10.1210/me.2007-0112 .
  33. Brix K, Führer D, Biebermann H . Molecules important for thyroid hormone synthesis and action - known facts and future perspectives . Thyroid Research . 4 . Suppl. 1 . S9 . August 2011 . 21835056 . 3155115 . 10.1186/1756-6614-4-S1-S9 . free .
  34. Book: Dabbs, David J . Diagnostic Immunohistochemistry. vanc . Elsevier. 2019. 345–389.
  35. Izumi . M. . Larsen . P. Reed . June 1, 1977 . Triiodothyronine, Thyroxine, and Iodine in Purified Thyroglobulin from Patients with Graves' Disease . Journal of Clinical Investigation . 59 . 6 . 1105–1112 . 10.1172/JCI108734 . 0021-9738 . 577211. 372323 .
  36. Zhang . Xiaohan . Malik . Bhoomanyu . Young . Crystal . Zhang . Hao . Larkin . Dennis . Liao . Xiao-Hui . Refetoff . Samuel . Liu . Ming . Arvan . Peter . May 23, 2022 . Maintaining the thyroid gland in mutant thyroglobulin-induced hypothyroidism requires thyroid cell proliferation that must continue in adulthood . The Journal of Biological Chemistry . 298 . 7 . 102066 . 10.1016/j.jbc.2022.102066 . 1083-351X . 9213252 . 35618019. free .
  37. Book: Boron, W.F. . Medical Physiology: A Cellular And Molecular Approach . Elsevier/Saunders . 2003 . 1416023283 .
  38. Marmelstein . Alan M. . Lobba . Marco J. . Mogilevsky . Casey S. . Maza . Johnathan C. . Brauer . Daniel D. . Francis . Matthew B. . 2020-03-18 . Tyrosinase-Mediated Oxidative Coupling of Tyrosine Tags on Peptides and Proteins . Journal of the American Chemical Society . 142 . 11 . 5078–5086 . 10.1021/jacs.9b12002 . 1520-5126 . 32093466.
  39. Ahad F, Ganie SA . Iodine, Iodine metabolism and Iodine deficiency disorders revisited . Indian Journal of Endocrinology and Metabolism . 14 . 1 . 13–17 . January 2010 . 21448409 . 3063534 .
  40. Nilsson . M. . 2001 . Iodide handling by the thyroid epithelial cell . Experimental and Clinical Endocrinology & Diabetes. 109 . 1 . 13–17 . 10.1055/s-2001-11014 . 0947-7349 . 11573132. 37723663 .
  41. Martín . Mariano . Salleron . Lisa . Peyret . Victoria . Geysels . Romina Celeste . Darrouzet . Elisabeth . Lindenthal . Sabine . Bernal Barquero . Carlos Eduardo . Masini-Repiso . Ana María . Pourcher . Thierry . Nicola . Juan Pablo . July 1, 2021 . The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane . FASEB Journal. 35 . 8 . e21681 . 10.1096/fj.202100303R . free . 1530-6860 . 34196428. 235698589 .
  42. Ahad . Farhana . Ganie . Shaiq A. . 2010 . Iodine, Iodine metabolism and Iodine deficiency disorders revisited . Indian Journal of Endocrinology and Metabolism . 14 . 1 . 13–17 . 2230-8210 . 3063534 . 21448409.
  43. den Hartog . M. T. . Sijmons . C. C. . Bakker . O. . Ris-Stalpers . C. . de Vijlder . J. J. . 1995 . Importance of the content and localization of tyrosine residues for thyroxine formation within the N-terminal part of human thyroglobulin . European Journal of Endocrinology . 132 . 5 . 611–617 . 10.1530/eje.0.1320611 . 0804-4643 . 7749504.
  44. Li . Dongdong . Zhang . Yuping . Fan . Zhiying . Chen . Jie . Yu . Jihong . 2015-11-01 . Coupling of chromophores with exactly opposite luminescence behaviours in mesostructured organosilicas for high-efficiency multicolour emission . Chemical Science . 6 . 11 . 6097–6101 . 10.1039/c5sc02044a . 2041-6520 . 6054107 . 30090223.
  45. Darragh . Alison J. . Moughan . Paul J. . 2005 . The effect of hydrolysis time on amino acid analysis . Journal of AOAC International . 88 . 3 . 888–893 . 10.1093/jaoac/88.3.888 . 1060-3271 . 16001867. free .
  46. Jim . Susan . Jones . Vicky . Copley . Mark S. . Ambrose . Stanley H. . Evershed . Richard P. . 2003 . Effects of hydrolysis on the delta13C values of individual amino acids derived from polypeptides and proteins . Rapid Communications in Mass Spectrometry . 17 . 20 . 2283–2289 . 10.1002/rcm.1177 . 0951-4198 . 14558127.
  47. Brent . Gregory A. . 2012-09-04 . Mechanisms of thyroid hormone action . The Journal of Clinical Investigation . 122 . 9 . 3035–3043 . 10.1172/JCI60047 . 0021-9738 . 3433956 . 22945636.
  48. Kansagra SM, McCudden CR, Willis MS . The Challenges and Complexities of Thyroid Hormone Replacement. Laboratory Medicine. June 2010. 41. 6. 338–348. 10.1309/LMB39TH2FZGNDGIM. free.
  49. St Germain DL, Galton VA, Hernandez A . Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges . Endocrinology . 150 . 3 . 1097–1107 . March 2009 . 19179439 . 2654746 . 10.1210/en.2008-1588 .
  50. Book: Wass. John A.H.. Stewart. Paul M. . vanc . Oxford Textbook of Endocrinology and Diabetes. 2011. Oxford University Press. Oxford. 978-0-19-923529-2. 565. 2nd.
  51. Book: Wass. John A.H.. Stewart. Paul M.. vanc. Oxford Textbook of Endocrinology and diabetes. 2011. Oxford University Press. Oxford. 978-0-19-923529-2. 18. 2nd.
  52. Book: Eugster . Erica A. . Pescovitz . Ora Hirsch . vanc . Pediatric endocrinology: mechanisms, manifestations and management . Lippincott Williams & Wilkins . Hagerstwon, MD . 2004 . 493 (Table 33-3) . 978-0-7817-4059-3 .
  53. Zoeller RT . Transplacental thyroxine and fetal brain development . The Journal of Clinical Investigation . 111 . 7 . 954–957 . April 2003 . 12671044 . 152596 . 10.1172/JCI18236 .
  54. Zimmermann . Michael B. . Boelaert . Kristien . January 12, 2015 . Iodine deficiency and thyroid disorders . The Lancet. Diabetes & Endocrinology . 3 . 4 . 286–295 . 10.1016/S2213-8587(14)70225-6 . 2213-8595 . 25591468.
  55. Book: Henry's clinical diagnosis and management by laboratory methods. McPherson, Richard A.,, Pincus, Matthew R.. 9780323413152. 23rd . St. Louis, Mo.. 949280055. McPherson. Richard A.. Pincus. Matthew R.. 5 April 2017.
  56. Bähre . M. . Hilgers . R. . Lindemann . C. . Emrich . D. . 1987 . Physiological aspects of the thyroid trapping function and its suppression in iodine deficiency using 99mTc pertechnetate . Acta Endocrinologica . 115 . 2 . 175–182 . 10.1530/acta.0.1150175 . 0001-5598 . 3037834.
  57. Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ . Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability . Endocrine Reviews . 22 . 4 . 451–476 . August 2001 . 11493579 . 10.1210/edrv.22.4.0435 . free . 1765/9707 . free .
  58. Dietrich JW, Brisseau K, Boehm BO . [Absorption, transport and bio-availability of iodothyronines] . Deutsche Medizinische Wochenschrift . 133 . 31–32 . 1644–1648 . August 2008 . 18651367 . 10.1055/s-0028-1082780 .
  59. Suzuki S, Suzuki N, Mori J, Oshima A, Usami S, Hashizume K . micro-Crystallin as an intracellular 3,5,3′-triiodothyronine holder in vivo . Molecular Endocrinology . 21 . 4 . 885–894 . April 2007 . 17264173 . 10.1210/me.2006-0403 . free .
  60. Mullur R, Liu YY, Brent GA . Thyroid hormone regulation of metabolism . Physiological Reviews . 94 . 2 . 355–382 . April 2014 . 24692351 . 4044302 . 10.1152/physrev.00030.2013 .
  61. Wu Y, Koenig RJ . Gene regulation by thyroid hormone . Trends in Endocrinology and Metabolism . 11 . 6 . 207–211 . August 2000 . 10878749 . 10.1016/s1043-2760(00)00263-0 . 44602986 .
  62. Ayers S, Switnicki MP, Angajala A, Lammel J, Arumanayagam AS, Webb P . Genome-wide binding patterns of thyroid hormone receptor beta . PLOS ONE . 9 . 2 . e81186 . 2014 . 24558356 . 3928038 . 10.1371/journal.pone.0081186 . 2014PLoSO...981186A . free .
  63. Martin NP, Marron Fernandez de Velasco E, Mizuno F, Scappini EL, Gloss B, Erxleben C, Williams JG, Stapleton HM, Gentile S, Armstrong DL . 6 . A rapid cytoplasmic mechanism for PI3-kinase regulation by the nuclear thyroid hormone receptor, TRβ, and genetic evidence for its role in the maturation of mouse hippocampal synapses in vivo . Endocrinology . 155 . 9 . 3713–3724 . September 2014 . 24932806 . 4138568 . 10.1210/en.2013-2058 .
  64. Hönes GS, Rakov H, Logan J, Liao XH, Werbenko E, Pollard AS, Præstholm SM, Siersbæk MS, Rijntjes E, Gassen J, Latteyer S, Engels K, Strucksberg KH, Kleinbongard P, Zwanziger D, Rozman J, Gailus-Durner V, Fuchs H, Hrabe de Angelis M, Klein-Hitpass L, Köhrle J, Armstrong DL, Grøntved L, Bassett JH, Williams GR, Refetoff S, Führer D, Moeller LC . 6 . Noncanonical thyroid hormone signaling mediates cardiometabolic effects in vivo . Proceedings of the National Academy of Sciences of the United States of America . 114 . 52 . E11323–E11332 . December 2017 . 29229863 . 5748168 . 10.1073/pnas.1706801115 . 2017PNAS..11411323H . free .
  65. Jewhurst K, Levin M, McLaughlin KA . Optogenetic Control of Apoptosis in Targeted Tissues of Xenopus laevis Embryos . Journal of Cell Death . 7 . 25–31 . 2014 . 25374461 . 4213186 . 10.4137/JCD.S18368 .
  66. Venturi, Sebastiano . Evolutionary Significance of Iodine . Current Chemical Biology . 5 . 155–162 . 2011 . 1872-3136 . 10.2174/187231311796765012 . 3.
  67. Venturi S, Venturi M . Iodine, PUFAs and Iodolipids in Health and Disease: An Evolutionary Perspective . Human Evolution . 29 . 1–3 . 185–205 . 2014 .
  68. Tamura K, Takayama S, Ishii T, Mawaribuchi S, Takamatsu N, Ito M . Apoptosis and differentiation of Xenopus tail-derived myoblasts by thyroid hormone . Journal of Molecular Endocrinology . 54 . 3 . 185–192 . June 2015 . 25791374 . 10.1530/JME-14-0327 . free .
  69. Gelfand RA, Hutchinson-Williams KA, Bonde AA, Castellino P, Sherwin RS . Catabolic effects of thyroid hormone excess: the contribution of adrenergic activity to hypermetabolism and protein breakdown . Metabolism . 36 . 6 . 562–569 . June 1987 . 2884552 . 10.1016/0026-0495(87)90168-5 .
  70. Stockigt. Jim R. January 2002. Case finding and screening strategies for thyroid dysfunction. Clinica Chimica Acta. 315. 1–2. 111–124. 10.1016/s0009-8981(01)00715-x. 11728414. 0009-8981.
  71. http://www.brooksidepress.org/Products/Military_OBGYN/Lab/ThyroidFunctionTests.htm Military Obstetrics & Gynecology > Thyroid Function Tests
  72. Polak M, Luton D. March 2014. Fetal thyroïdology. Best Practice & Research. Clinical Endocrinology & Metabolism. 28. 2. 161–73. 10.1016/j.beem.2013.04.013. 24629859.
  73. Kirkegaard C, Faber J . The role of thyroid hormones in depression . European Journal of Endocrinology . 138 . 1 . 1–9 . January 1998 . 9461307 . 10.1530/eje.0.1380001 . free .
  74. Dratman MB, Gordon JT . Thyroid hormones as neurotransmitters . Thyroid . 6 . 6 . 639–647 . December 1996 . 9001201 . 10.1089/thy.1996.6.639 .
  75. 10.1161/CIRCULATIONAHA.118.036859 . free . 6851449 . 31081673. Thyroid and Cardiovascular Disease . 2019 . Cappola . Anne R. . Desai . Akshay S. . Medici . Marco . Cooper . Lawton S. . Egan . Debra . Sopko . George . Fishman . Glenn I. . Goldman . Steven . Cooper . David S. . Mora . Samia . Kudenchuk . Peter J. . Hollenberg . Anthony N. . McDonald . Cheryl L. . Ladenson . Paul W. . Celi . Francesco S. . Dillman . Wolfgang . Ellervik . Christina . Gerdes . A. Martin . Ho . Carolyn . Iervasi . Giorgio . Lerman . Amir . Makino . Ayako . Ojamaa . Kaie . Peeters . Robin . Pingitore . Alessandro . Razvi . Salman . Wassner . Ari J. . Circulation . 139 . 25 . 2892–2909 .
  76. Parry CH. Elements of Pathology and Therapeutics, Being the Outlines of a Work. Bath, England: R. Cruttwell, 1815.
  77. Web site: Myopathies associated with thyroid disease . 2023-06-09 . MedLink Neurology . en.
  78. Rodolico . Carmelo . Bonanno . Carmen . Pugliese . Alessia . Nicocia . Giulia . Benvenga . Salvatore . Toscano . Antonio . 2020-09-01 . Endocrine myopathies: clinical and histopathological features of the major forms . Acta Myologica . 39 . 3 . 130–135 . 10.36185/2532-1900-017 . 1128-2460 . 7711326 . 33305169.
  79. Celsing . F. . Blomstrand . E. . Melichna . J. . Terrados . N. . Clausen . N. . Lins . P. E. . Jansson . E. . April 1986 . Effect of hyperthyroidism on fibre-type composition, fibre area, glycogen content and enzyme activity in human skeletal muscle . Clinical Physiology (Oxford, England) . 6 . 2 . 171–181 . 10.1111/j.1475-097x.1986.tb00066.x . 0144-5979 . 2937605.
  80. Sharma . Vikas . Borah . Papori . Basumatary . Lakshya J. . Das . Marami . Goswami . Munindra . Kayal . Ashok K. . 2014 . Myopathies of endocrine disorders: A prospective clinical and biochemical study . Annals of Indian Academy of Neurology . 17 . 3 . 298–302 . 10.4103/0972-2327.138505 . 0972-2327 . 4162016 . 25221399 . free .
  81. Dimitriadis . G D . Leighton . B . Parry-Billings . M . West . D . Newsholme . E A . 1989-01-15 . Effects of hypothyroidism on the sensitivity of glycolysis and glycogen synthesis to insulin in the soleus muscle of the rat. . Biochemical Journal . 257 . 2 . 369–373 . 10.1042/bj2570369 . 0264-6021 . 1135589 . 2649073.
  82. Berbel P, Navarro D, Ausó E, Varea E, Rodríguez AE, Ballesta JJ, Salinas M, Flores E, Faura CC, de Escobar GM . 6 . Role of late maternal thyroid hormones in cerebral cortex development: an experimental model for human prematurity . Cerebral Cortex . 20 . 6 . 1462–1475 . June 2010 . 19812240 . 2871377 . 10.1093/cercor/bhp212 .
  83. Korevaar TI, Muetzel R, Medici M, Chaker L, Jaddoe VW, de Rijke YB, Steegers EA, Visser TJ, White T, Tiemeier H, Peeters RP . 6 . Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study . The Lancet. Diabetes & Endocrinology . 4 . 1 . 35–43 . January 2016 . 26497402 . 10.1016/s2213-8587(15)00327-7 . 1765/79096 . free .
  84. Szinnai G . Genetics of normal and abnormal thyroid development in humans . Best Practice & Research. Clinical Endocrinology & Metabolism . 28 . 2 . 133–150 . March 2014 . 24629857 . 10.1016/j.beem.2013.08.005 .
  85. Spiegel C, Bestetti GE, Rossi GL, Blum JW . Normal circulating triiodothyronine concentrations are maintained despite severe hypothyroidism in growing pigs fed rapeseed presscake meal . The Journal of Nutrition . 123 . 9 . 1554–1561 . September 1993 . 8360780 . 10.1093/jn/123.9.1554 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Thyroid hormones".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.